Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 501 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 301-325 of 501 matching filings.

Per page
25
Current page
13
424B3 File 333-265731

PROSPECTUS

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265731

EFFECT filing

Filing date
29 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-265731

AMENDMENT NO. 1 TO FORM S-1

Filing date
24 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
8-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 8-K

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
22 Jun 2022
Reporting date
17 Jun 2022
Next action
Verify source filing
S-1 File 333-265731

REGISTRATION STATEMENT

Filing date
21 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
10 Jun 2022
Reporting date
09 Jun 2022
Next action
Verify source filing
D File 021-448510

D filing

Filing date
08 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
07 Jun 2022
Reporting date
06 Jun 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
06 Jun 2022
Reporting date
01 Jun 2022
Next action
Verify source filing
424B5 File 333-262532

PROSPECTUS SUPPLEMENT

Filing date
06 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-262532

PROSPECTUS SUPPLEMENT

Filing date
01 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 May 2022
Reporting date
12 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
18 May 2022
Reporting date
12 May 2022
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
13 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
06 May 2022
Reporting date
05 May 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
28 Apr 2022
Reporting date
28 Apr 2022
Next action
Verify source filing
424B3 File 333-264187

PROSPECTUS

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
21 Apr 2022
Reporting date
21 Apr 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .